Journal article · 2024 · Open access
Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques
Gene Therapy, 32(1), 16–24 · Published 18 July 2024 · DOI 10.1038/s41434-024-00467-9
In brief
“Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques” is a 2024 journal article by Brian Hetrick and 13 co-authors, published in Gene Therapy. OpenAlex counts 2 citations as of 18 November 2026, which puts it in the top 5% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Gene Therapy.
- Citations
- 2
- Most cited in
- 2026 (2)
- Field-weighted impact
- 0.28
- References
- 64
- Authors
- 14
Abstract
Persistence of human immunodeficiency virus (HIV) reservoirs prevents viral eradication, and consequently HIV-infected patients require lifetime treatment with antiretroviral therapy (ART) [1-5]. Currently, there are no effective therapeutics to prevent HIV rebound upon ART cessation. Here we describe an HIV/SIV Rev-dependent lentiviral particle that can be administered to inhibit viral rebound [6-9]. Using simian immunodeficiency virus (SIV)-infected rhesus macaques as a model, we demonstrate that the administration of pre-assembled SIV Rev-dependent lentiviral particles into SIVmac239-infected Indian rhesus macaques can lead to reduction of viral rebound upon ART termination. One of the injected animals, KC50, controlled plasma and CNS viremia to an undetectable level most of the time for over two years after ART termination. Surprisingly, detailed molecular and immunological characterization revealed that viremia control was concomitant with the induction of neutralizing antibodies (nAbs) following the administration of the Rev-dependent vectors. This study emphasizes the importance of neutralizing antibodies (nAbs) for viremia control [10-15], and also provides proof of concept that the Rev-dependent vector can be used to target viral reservoirs, including the CNS reservoirs, in vivo. However, future large-scale in vivo studies are needed to understand the potential mechanisms of viremia control induced by the Rev-dependent vector.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hetrick, B., Siddiqui, S., Spear, M., Guo, J., Liang, H., Fu, Y., Yang, Z., Doyle‐Meyers, L. A., Pahar, B., Veazey, R. S., Dufour, J., Andalibi, A., Ling, B., & Wu, Y. (2024). Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques. Gene Therapy, 32(1), 16–24. https://doi.org/10.1038/s41434-024-00467-9
MLA 9
Hetrick, Brian, et al. “Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques.” Gene Therapy, vol. 32, no. 1, 2024, pp. 16–24. https://doi.org/10.1038/s41434-024-00467-9.
Chicago
Hetrick, Brian, Summer Siddiqui, Mark Spear, Jia Guo, Huizhi Liang, Yajing Fu, Zhijun Yang, et al. 2024. “Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques.” Gene Therapy 32 (1): 16–24. https://doi.org/10.1038/s41434-024-00467-9.
Harvard
Hetrick, B. et al. (2024) ‘Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques’, Gene Therapy, 32(1), pp. 16–24. doi:10.1038/s41434-024-00467-9.
IEEE
B. Hetrick et al., “Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques,” Gene Therapy, vol. 32, no. 1, pp. 16–24, 2024, doi: 10.1038/s41434-024-00467-9.
BibTeX
@article{hetrick2024suppression,
title = {{Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques}},
author = {Hetrick, Brian and Siddiqui, Summer and Spear, Mark and Guo, Jia and Liang, Huizhi and Fu, Yajing and Yang, Zhijun and Doyle‐Meyers, Lara A. and Pahar, Bapi and Veazey, Ronald S. and Dufour, Jason and Andalibi, Ali and Ling, Binhua and Wu, Yuntao},
journal = {Gene Therapy},
year = {2024},
volume = {32},
number = {1},
pages = {16--24},
doi = {10.1038/s41434-024-00467-9},
url = {https://doi.org/10.1038/s41434-024-00467-9}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- HIV reservoir
- viral rebound
- simian immunodeficiency virus
- rhesus monkeys
- neutralizing antibodies
- antiretroviral therapy discontinuation
- SIVmac239
- HIV cure
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Hetrick, B., Siddiqui, S., Spear, M., Guo, J., Liang, H., Fu, Y., Yang, Z., Doyle‐Meyers, L. A., Pahar, B., Veazey, R. S., Dufour, J., Andalibi, A., Ling, B., & Wu, Y. (2024). Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques. Gene Therapy, 32(1), 16–24. https://doi.org/10.1038/s41434-024-00467-9
How many times has this paper been cited?
2 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Gene Therapy: sign in and open the PDF from this page.
Who wrote this paper?
Brian Hetrick, Summer Siddiqui, Mark Spear, Jia Guo, Huizhi Liang, Yajing Fu, Zhijun Yang, Lara A. Doyle‐Meyers, Bapi Pahar, Ronald S. Veazey, Jason Dufour, Ali Andalibi and 2 more.
What is the DOI of this paper?
10.1038/s41434-024-00467-9, permanently at https://doi.org/10.1038/s41434-024-00467-9. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.